Research-backed articles on peptides, women's longevity, perimenopause science, and female biology. Written for Australian and New Zealand women who want real answers.
Retatrutide is the first triple GIP/GLP-1/glucagon receptor agonist with Phase 2 clinical data. For women navigating perimenopausal metabolic resistance, its mechanism maps dire...
Epithalon is one of the few longevity peptides with published human clinical data — on telomere elongation, melatonin restoration, and biological age markers. Here's what Austra...
NAD+ levels drop by up to 50% by midlife. For women, the consequences are disproportionate. Here's what the research shows and why it matters.
Brain fog, sleep disruption, skin changes, weight resistance. The perimenopause research gap is real — and peptide science is beginning to fill it.
GHK-Cu influences the expression of over 4,000 human genes — and its natural levels decline with age. Here's what the research shows about collagen, skin, and why this compound ...
BPC-157 is one of the most searched peptide compounds in Australia. Here's what the research actually shows — and why women's biology responds uniquely.
Most peptide research was conducted on men. Most protocols were designed for men. Here's the comprehensive guide Australian women have been waiting for.
